|
|
||||||||
National Center for Health Statistics, Hyattsville, Md. 20782, USA.
OBJECTIVES: The prophylactic effect of aspirin (at 80 mg/day) for the prevention of cardiovascular disease mortality has long been recognized. This study examined whether other salicylates are present in comparable quantities in the US food supply. METHODS: To estimate the order of magnitude for salicylates in the food supply, annual production data for selected synthetic salicylates were analyzed. RESULTS: Production figures for 1960 indicate exposure to salicylates of 250 mg/day per person, or 95 mg/day per person excluding aspirin. Trend data indicate a rise in the production of salicylates over time, reaching 341 mg/day per person, or 126 mg/day per person excluding aspirin, in 1970. CONCLUSIONS: The US ingestion of salicylates with aspirinlike properties may have increased to the point that many susceptible individuals have received a beneficial effect that has contributed to the decline in cardiovascular disease mortality.
Related articles in AJPH:
This article has been cited by other articles:
![]() |
J R Lawrence, R Peter, G J Baxter, J Robson, A B Graham, and J R Paterson Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin J. Clin. Pathol., September 1, 2003; 56(9): 651 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sans and A. Evans Are cardiovascular disease trends driven by gadflies? Int. J. Epidemiol., June 1, 2001; 30(3): 624 - 625. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |